Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chromium picolinate supplementation "beneficial" in type 2 diabetics in USDA study.

This article was originally published in The Tan Sheet

Executive Summary

CHROMIUM PICOLINATE ELEVATED INTAKE FOUND "BENEFICIAL" FOR DIABETICS in a study by Richard Anderson, PhD, U.S. Department of Agriculture, et al., in collaboration with Beijing Medical University. Published in the November issue of Diabetes, the research involved 180 subjects 35 to 65 with type 2 adult-onset diabetes. Patients received chromium picolinate in 200 mcg or 1,000 mcg doses daily or placebo. "Improvements in fasting glucose and insulin concentrations as well as those after a glucose challenge document the role of elevated intakes of supplemental chromium in the control of type 2 diabetes," the study says.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087738

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel